
IV tranexamic acid reduces blood loss and transfusion rate in primary THA

IV tranexamic acid reduces blood loss and transfusion rate in primary THA
Meta-analysis of Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty
Orthopedics. 2016 Sep 1;39(5):e883-92Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixteen randomized controlled trials (RCTs) were included in this meta-analysis evaluating the efficacy and safety of intravenous tranexamic acid in total hip arthroplasty. All included trials were placebo controlled. Results demonstrated significantly lower blood loss - including intraoperative blood loss, postoperative blood loss, and total blood loss - and transfusion rate with IV TXA versus pl...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.